Report of the 7th African Rotavirus Symposium, Cape Town, South Africa, 8th November 2012.
The 7th African Rotavirus Symposium was held in Cape Town, South Africa, on the 8th November 2012 as a Satellite Symposium at the First International African Vaccinology Conference. Over 150 delegates participated in this symposium including scientists, clinicians, health officials, policymakers and vaccine manufacturers from across Africa. Key topics discussed included rotavirus surveillance, rotavirus vaccine introduction, post rotavirus vaccine impact analysis and intussusception data and surveillance in Africa. The symposium provided early rotavirus vaccine adopter countries in Africa (South Africa, Ghana and Botswana) an opportunity to share up-to-date information on vaccine introduction, and allowed colleagues to share experiences in establishing routine rotavirus surveillance (Tanzania, Niger and Rwanda). Overall, the symposium highlighted the high burden of rotavirus in Africa, and the need to continue to strengthen efforts in preventing rotavirus diarrhoea in Africa.
MRC/Diarrhoeal Pathogens Research Unit, Department of Virology, Medunsa Campus, University of Limpopo/National Health Laboratory Service, Pretoria, South Africa.
L M
LM
Seheri
African Rotavirus Surveillance Network, Immunization, Vaccines and Development Cluster, WHO African Regional Office, Brazzaville, Congo.
J M
JM
Mwenda
MRC/Diarrhoeal Pathogens Research Unit, Department of Virology, Medunsa Campus, University of Limpopo/National Health Laboratory Service, Pretoria, South Africa; Centre for Enteric Diseases, National Institute for Communicable Diseases, A division of the National Health Laboratory Services, Johannesburg, South Africa. Electronic address: nicolap@nicd.ac.za.
N
N
Page
D000349:Africa / Q000453:epidemiology; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D003967:Diarrhea / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D062665:Epidemiological Monitoring; D017589:Immunization Programs; D007443:Intussusception; D011358:Product Surveillance, Postmarketing; D012401:Rotavirus; D012400:Rotavirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D013019:South Africa
D022243:Rotavirus Vaccines
Clinical trials; Epidemiology; Intussusception; Post marketing; Rotavirus in Africa; Vaccine